STAT+: Pharmalittle: We’re reading about HIV drug resistance, march-in rights, and more

The World Health Organization said resistance to GSK’s HIV drug dolutegravir has exceeded levels observed during its clinical trials.
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks